- Home
- TNGX vs MANH Comparison
TNGX vs MANH Comparison
Compare TNGX & MANH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- MANH
- Stock Information
- Founded
- TNGX 2014
- MANH 1990
- Country
- TNGX United States
- MANH United States
- Employees
- TNGX N/A
- MANH N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- MANH Computer Software: Prepackaged Software
- Sector
- TNGX Health Care
- MANH Technology
- Exchange
- TNGX Nasdaq
- MANH Nasdaq
- Market Cap
- TNGX 735.0M
- MANH 17.2B
- IPO Year
- TNGX N/A
- MANH 1998
- Fundamental
- Price
- TNGX $6.64
- MANH $292.32
- Analyst Decision
- TNGX Strong Buy
- MANH Strong Buy
- Analyst Count
- TNGX 8
- MANH 8
- Target Price
- TNGX $15.14
- MANH $275.75
- AVG Volume (30 Days)
- TNGX 885.7K
- MANH 400.4K
- Earning Date
- TNGX 11-06-2024
- MANH 10-22-2024
- Dividend Yield
- TNGX N/A
- MANH N/A
- EPS Growth
- TNGX N/A
- MANH 42.01
- EPS
- TNGX N/A
- MANH 3.28
- Revenue
- TNGX $42,509,000.00
- MANH $996,566,000.00
- Revenue This Year
- TNGX $18.15
- MANH $14.35
- Revenue Next Year
- TNGX N/A
- MANH $11.02
- P/E Ratio
- TNGX N/A
- MANH $89.13
- Revenue Growth
- TNGX 26.16
- MANH 17.49
- 52 Week Low
- TNGX $6.33
- MANH $182.97
- 52 Week High
- TNGX $13.01
- MANH $307.50
- Technical
- Relative Strength Index (RSI)
- TNGX 37.15
- MANH 56.51
- Support Level
- TNGX $6.83
- MANH $300.76
- Resistance Level
- TNGX $7.47
- MANH $306.40
- Average True Range (ATR)
- TNGX 0.37
- MANH 5.39
- MACD
- TNGX 0.11
- MANH -0.57
- Stochastic Oscillator
- TNGX 27.31
- MANH 50.70
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About MANH Manhattan Associates Inc.
Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers around the world.